1 citations,
March 1995 in “Pharmacoepidemiology and drug safety” Taking oral contraceptives while on isotretinoin may increase the risk of high triglyceride and cholesterol levels.
November 2024 in “JAMA Dermatology” An international expert consensus statement was developed to guide the off-label use of low-dose oral minoxidil (LDOM) for hair loss, involving 43 dermatologists from 12 countries. Through a modified Delphi process, consensus was reached on 76 items, including diagnoses, dosing for adults and adolescents, contraindications, and monitoring. However, consensus was not achieved for pediatric use and titration protocols. The statement aims to assist clinical practice until more data are available, highlighting the need for further research on pediatric use, comparative efficacy with topical minoxidil, long-term safety, and other off-label minoxidil forms.
November 2024 in “Actas Dermo-Sifiliográficas” The study evaluated the effectiveness of low-dose oral minoxidil in treating frontal fibrosing alopecia (FFA) in 122 patients across centers in Brazil and Spain. Results showed that 45.1% of patients experienced subjective improvement in the frontotemporal hairline, with varying degrees of mild (34.4%), moderate (9.0%), and excellent (1.6%) improvement. Additionally, 57.4% saw improved hair density in the interparietal area, while 25.4% and 3.3% experienced eyebrow and eyelash growth, respectively. Adverse effects were reported in 33.6% of patients, with hypertrichosis being the most common at 23.8%. The study concluded that oral minoxidil is an effective additional therapy for FFA, enhancing hair and eyebrow growth and frontotemporal hairline density.
October 2024 in “International Journal of Dermatology” Oral and topical minoxidil are equally effective for hair loss, but oral minoxidil causes more unwanted hair growth.
This study compared the efficacy and safety of topical Minoxidil 5% alone versus combined with Dutasteride (either topical 0.02% through microneedling or oral 0.5 mg) in treating androgenetic alopecia (AGA) in 30 patients (24 males, 6 females). Over 16 weeks, all groups showed significant improvement, with the combination treatments (groups B and C) yielding better results in hair density and width than Minoxidil alone (group A). Group C, using topical Dutasteride with microneedling, showed the highest improvement and fewer systemic side effects compared to oral Dutasteride. The study concluded that combining Minoxidil with topical Dutasteride via microneedling is a promising and effective treatment for AGA with minimal side effects.
September 2024 in “Journal of the American Academy of Dermatology” Media attention increased oral minoxidil prescriptions for English-preferring patients but not for Spanish-preferring patients.
September 2024 in “Journal of the American Academy of Dermatology” The New York Times article boosted interest in using low dose oral minoxidil for hair loss.
September 2024 in “Journal of the American Academy of Dermatology” Experts agree on guidelines for safely using low-dose oral minoxidil to treat hair loss.
September 2024 in “Journal of the American Academy of Dermatology” Oral minoxidil is easier to use and more satisfying for hair loss treatment but may cause more unwanted hair growth.
August 2024 in “Pakistan Journal of Health Sciences” PRP with finasteride is better for hair regrowth than minoxidil with finasteride.
August 2024 in “Bioorganic Chemistry” Cedrol from ginger can promote hair growth when taken orally.
August 2024 in “Skin Research and Technology” Low-dose oral minoxidil can help increase hair growth in women with hair loss.
July 2024 in “Skin Appendage Disorders” The supplement significantly improves hair density and appearance in people with hair loss.
July 2024 in “The journal of investigative dermatology/Journal of investigative dermatology” Using both topical and oral minoxidil does not reduce hair shedding.
July 2024 in “Journal of Investigative Dermatology” Most women continued using oral minoxidil for hair loss despite mild to moderate side effects.
July 2024 in “Journal of the American Academy of Dermatology” Low-dose oral minoxidil is generally safe for hypertensive patients with hair loss.
June 2024 in “British Journal of Dermatology” PRP with topical minoxidil is the most effective treatment for increasing hair density in androgenetic alopecia.
June 2024 in “British Journal of Dermatology” Combining PRP with topical minoxidil is the most effective for increasing hair density in male pattern baldness.
June 2024 in “European Journal of Clinical and Experimental Medicine” Oral minoxidil for hair loss can cause weight gain due to fluid retention.
June 2024 in “Dermatology and therapy” Low-dose oral minoxidil is safe for treating children's hair disorders.
Media coverage led to more dermatologists prescribing low-dose oral minoxidil for hair loss.
May 2024 in “JAMA Dermatology” Oral contraceptive use may increase the risk of frontal fibrosing alopecia in women with a specific CYP1B1 gene variant.
Oral minoxidil works as well as topical minoxidil for male pattern baldness.
May 2024 in “Anais brasileiros de dermatologia/Anais Brasileiros de Dermatologia” Oral minoxidil 7.5 mg for hair loss increases heart rate but not blood pressure.
April 2024 in “Anais brasileiros de dermatologia/Anais Brasileiros de Dermatologia” Using both minoxidil and biotin together increased hair growth more than using either one alone.
April 2024 in “Skin appendage disorders” Oral finasteride seems more effective for hair loss in postmenopausal women, but more research is needed.
April 2024 in “Clinical and experimental dermatology” Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.
April 2024 in “International Journal of Dermatology” Oral minoxidil may worsen hangover symptoms when combined with alcohol.
April 2024 in “JAMA dermatology” Oral minoxidil is as effective as topical minoxidil for male hair loss but has more side effects like excessive hair growth and headaches.
March 2024 in “JAAD International” Using both topical and oral minoxidil doesn't significantly reduce temporary hair shedding.